Target intelligence / Profile preview

Abnormal host cells recognized by NK cells via stress ligands and altered MHC class I

Molecular classification
Cellular phenotype, Killer-cell immunoglobulin-like receptor (KIR) ligands, NKG2D ligands, MHC class I molecules
01

Overview

Abnormal host cells recognized by NK cells via stress ligands and altered MHC class I refers to a cellular state, typically found in malignant or virally infected cells, that renders them susceptible to Natural Killer (NK) cell-mediated destruction. This recognition is governed by a balance of signals: the 'missing-self' mechanism occurs when cells downregulate MHC class I to evade T-cells, which removes inhibitory signals to NK cell Killer-cell Immunoglobulin-like Receptors (KIRs) (Ljunggren & Kärre, 1990, Immunology Today). Concurrently, 'induced-self' recognition involves the upregulation of stress-induced ligands (such as MICA, MICB, and ULBPs) that bind to the activating receptor NKG2D on NK cells (Lanier, 2015, Nature Reviews Immunology). In therapeutic contexts, this axis is targeted by checkpoint inhibitors like Lirilumab (anti-KIR) and Monalizumab (anti-NKG2A) to disinhibit NK cells, or by CAR-NK cells and bispecific engagers that specifically bind to stress ligands on the abnormal cells (Vivier et al., 2011, Science; André et al., 2018, Cell). This target description represents a physiological mechanism of immune evasion and recognition rather than a single molecular entity.

Other names
MHC-I deficient cellsStressed host cellsNKG2D ligand-expressing cellsMissing-self targetsInduced-self targets
02

Mechanism of action

Enhancement of NK cell-mediated cytotoxicity by blocking inhibitory receptors (e.g., KIR, NKG2A) or activating NK cells through stress-ligand recognition (e.g., NKG2D engagement).

03

Biological functions

Immune surveillanceCytolysisApoptosis inductionAntigen presentationImmune response
04

Disease associations

CancerInfectionAutoimmunity
05

Safety considerations

Cytokine release syndrome (CRS)Off-target toxicity to healthy stressed tissues (e.g., intestinal epithelium)Autoimmune reactionsTumor escape through ligand shedding
06

Interacting drugs

Lirilumab

4 more in the full profile.

07

Biomarkers

MICA/B expressionULBP1/2/3/4/5/6 expressionHLA-A/B/C downregulationNKG2D expressionKIR expression profile

Beyond the preview

Go deeper on Abnormal host cells recognized by NK cells via stress ligands and altered MHC class I.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Abnormal host cells recognized by NK cells via stress ligands and altered MHC class I.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call